Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Long Term Debt

As of the most recent data (June 2026), SRNGU shows a long-term debt of $400M. That compares with $430M in the prior-year period — down 5.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SRNGU's long-term debt is now $400M (was $430M) — a 5.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) is outperforming or lagging.

Tracking SRNGU's long-term debt over time shows whether Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $400M That compares with $430M in the prior-year period — down 5.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $400M) with ownership activity and broader fundamentals.

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s long-term debt is $400M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.